MétaCan
Menu
Back to cohort
Record W2394851933 · doi:10.1186/s12974-016-0588-5

Inflammatory profile in LRRK2-associated prodromal and clinical PD

2016· article· en· W2394851933 on OpenAlexafffund
Kathrin Brockmann, Anja Apel, Claudia Schulte, Nicole Schneiderhan‐Marra, Claustre Pont‐Sunyer, Dolores Vilas, Javier Ruiz‐Martínez, Markus Langkamp, Jean‐Christophe Corvol, Florence Cormier, Thomas Knorpp, Thomas Joos, Thomas Gasser, Birgitt Schüle, Jan Aasly, Tatiana Foroud, J.F. Martí-Massó, Alexis Brice, Eduardo Tolosa, Connie Marras, Daniela Berg, Walter Maetzler

Bibliographic record

VenueJournal of Neuroinflammation · 2016
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsUniversity of TorontoToronto Western Hospital
FundersNIH Clinical CenterCanadian Institutes of Health ResearchHorizon PharmaParkinsonfondenSt. Olavs Hospital Universitetssykehuset i TrondheimEMD SeronoDeutsches Zentrum für Neurodegenerative ErkrankungenH. Lundbeck A/SUniversity of TorontoEberhard Karls Universität TübingenEuropean CommissionBundesministerium für Bildung und ForschungParkinson Study GroupInstituto de Salud Carlos IIIUniversitat de BarcelonaMichael J. Fox Foundation for Parkinson's ResearchParkinson Society CanadaValeant Pharmaceuticals InternationalCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasGlaxoSmithKlineNational Parkinson FoundationRobert Bosch StiftungNorges Teknisk-Naturvitenskapelige UniversitetInstitut National de la Santé et de la Recherche MédicaleNational Center for Advancing Translational SciencesTeva Pharmaceutical Industries
KeywordsNeurologyMedicinePsychiatry

Abstract

fetched live from OpenAlex

BACKGROUND: There is evidence for a relevant role of inflammation in the pathogenesis of Parkinson's disease (PD). Mutations in the LRRK2 gene represent the most frequent genetic cause for autosomal dominant PD. LRRK2 is highly expressed in macrophages and microglia suggesting an involvement in inflammatory pathways. The objectives are to test (1) whether idiopathic PD and LRRK2-associated PD share common inflammatory pathways or present distinct profiles and (2) whether non-manifesting LRRK2 mutation carriers present with similar aspects of inflammatory profiles as seen in PD-affected patients. METHODS: We assessed serum profiles of 23 immune-associated markers and the brain-derived neurotrophic factor in 534 individuals from the MJFF LRRK2 consortium. RESULTS: A large proportion of inflammatory markers were gender-dependent. Both PD-affected cohorts showed increased levels of the pro-inflammatory marker fatty-acid-binding protein. Additionally, idiopathic PD but not LRRK2-associated PD patients showed increased levels of the pro-inflammatory marker interleukin-12-p40 as well as the anti-inflammatory species interleukin-10, brain-derived neurotrophic factor, and stem cell factor. Non-manifesting LRRK2 mutation carriers including those with prodromal characteristics of PD presented with control-like inflammatory profiles. CONCLUSIONS: Concomitant inflammation seems to be associated with idiopathic and LRRK2-associated PD. Identifying PD patients in whom inflammatory processes play a major role in their pathophysiology might offer a new therapeutic window at least for a subgroup of patients. Since non-manifesting LRRK2 mutation carriers with symptoms of the prodromal phase of PD did not show inflammatory profiles, activation of the immune system seems not an early event in the disease cascade.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.158
Threshold uncertainty score0.260

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.297
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations78
Published2016
Admission routes2
Has abstractyes

Explore more

Same venueJournal of NeuroinflammationSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207